ticagrelor and imidazole

ticagrelor has been researched along with imidazole* in 1 studies

Other Studies

1 other study(ies) available for ticagrelor and imidazole

Article	Year
Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24 ADP-mediated platelet aggregation is signaled through G protein-coupled receptors P2Y Topics: Animals; Binding Sites; Cytochrome P-450 Enzyme System; Drug Stability; Enzyme Inhibitors; Half-Life; Humans; Imidazoles; Mice; Microsomes, Liver; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rats; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Structure-Activity Relationship; Ticagrelor; Xanthine Oxidase	2020

Article

Year

Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y

Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24

ADP-mediated platelet aggregation is signaled through G protein-coupled receptors P2Y

Topics: Animals; Binding Sites; Cytochrome P-450 Enzyme System; Drug Stability; Enzyme Inhibitors; Half-Life; Humans; Imidazoles; Mice; Microsomes, Liver; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rats; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Structure-Activity Relationship; Ticagrelor; Xanthine Oxidase

2020